Jazz Pharmaceuticals plc Deferred Income Tax Expense (Benefit) in USD from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Jazz Pharmaceuticals plc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2010 to Q1 2025.
  • Jazz Pharmaceuticals plc Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2025 was -$43.8M, a 34% increase year-over-year.
  • Jazz Pharmaceuticals plc annual Deferred Income Tax Expense (Benefit) for 2024 was -$208M, a 19.9% increase from 2023.
  • Jazz Pharmaceuticals plc annual Deferred Income Tax Expense (Benefit) for 2023 was -$260M, a 11% increase from 2022.
  • Jazz Pharmaceuticals plc annual Deferred Income Tax Expense (Benefit) for 2022 was -$292M, a 522% decline from 2021.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)

Jazz Pharmaceuticals plc Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$43.8M +$22.6M +34% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q1 2024 -$66.4M -$324K -0.49% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q1 2023 -$66.1M -$20.7M -45.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 -$45.3M -$26.2M -137% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 -$19.1M +$44.9M +70.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 -$64M -$46.9M -275% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q1 2019 -$17.1M -$1.75M -11.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q1 2018 -$15.3M -$307K -2.05% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q1 2017 -$15M -$9.26M -161% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q1 2016 -$5.74M +$3.52M +38% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q1 2015 -$9.26M -$4.88M -112% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q1 2014 -$4.38M -$504K -13% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q1 2013 -$3.87M -$3.87M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q1 2012 $0 Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07

Jazz Pharmaceuticals plc Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$208M +$51.9M +19.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-26
2023 -$260M +$32M +11% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-26
2022 -$292M -$361M -522% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-26
2021 $69.2M +$206M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$137M +$99.7M +42.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$237M -$148M -166% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$88.8M +$137M +60.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 -$226M -$184M -448% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 -$41.2M +$27.2M +39.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 -$68.4M -$19.1M -38.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 -$49.3M -$39.2M -388% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 -$10.1M +$104M +91.1% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-23
2012 -$114M -$114M Jan 1, 2012 Dec 31, 2012 10-K 2015-02-24
2011 $0 $0 Jan 1, 2011 Dec 31, 2011 10-K 2014-02-25
2010 $0 Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.